A trial comparing radiotherapy 3 times a day with radiotherapy once a day for head and neck cancer (CH03)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasal and paranasal sinus cancer , Nasopharyngeal cancer, Pharyngeal cancer, Salivary gland cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at a new way of giving radiotherapy called CHARTWEL.

Radiotherapy is sometimes given after surgery for head and neck cancers. This is to try to stop the cancer coming back. This trial is comparing 2 different ways of giving radiotherapy to people at high or medium risk of a recurrence of their cancer. The trial is comparing radiotherapy 3 times a day (CHARTWEL) with once daily treatment (conventional radiotherapy). The trial is to see which type of radiotherapy is better at stopping the cancer from coming back. The study is also comparing the side effects.

Recruitment start: 1 July 2001

Recruitment end: 28 February 2005